Betnesol 0.5 Tablet (20) Information
Betnesol 0.5 Tablet (20) is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Allergy, Asthma, Cancer: causes, symptoms, treatment, medicines, prevention and medicines. The alternative uses of Betnesol 0.5 Tablet (20) have also been explained below.
The optimal dosage of Betnesol 0.5 Tablet (20) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Betnesol 0.5 Tablet (20) are Skin Rash. Besides the aforementioned side effects, there are other adverse effects of Betnesol 0.5 Tablet (20) as well, which are listed below. Such side effects of Betnesol 0.5 Tablet (20) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Betnesol 0.5 Tablet (20)'s effect during pregnancy is Moderate and Safe while nursing. In addition, Betnesol 0.5 Tablet (20)'s effects on the liver, heart and kidney are discussed below in the Betnesol 0.5 Tablet (20) related warnings section.
Betnesol 0.5 Tablet (20) is contraindicated in people with pre-existing medical conditions like Liver Disease, Scleroderma, Tuberculosis (TB) as it can result in adverse effects. Other contraindications of Betnesol 0.5 Tablet (20) have been discussed in the sections ahead.
Besides this, Betnesol 0.5 Tablet (20) may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Betnesol 0.5 Tablet (20), it is important to know that it is safe while driving, and is habit-forming.
Betnesol 0.5 Tablet (20) Benefits & Uses
Betnesol 0.5 Tablet (20) is used to treat the following -
Main Benefits
Other Benefits
Betnesol 0.5 Tablet (20) Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Betnesol 0.5 Tablet (20) Related Warnings
-
Is the use of Betnesol 0.5 Tablet (20) safe for pregnant women?
Betnesol can have harmful effects in pregnant women. If you experience any discomfort after using Betnesol, then discontinue the use and take your doctor's advice.
Moderate -
Is the use of Betnesol 0.5 Tablet (20) safe during breastfeeding?
Betnesol is completely safe for breastfeeding women.
Safe -
What is the effect of Betnesol 0.5 Tablet (20) on the Kidneys?
Betnesol rarely harms the kidneys.
Mild -
What is the effect of Betnesol 0.5 Tablet (20) on the Liver?
Very few cases of side effects of Betnesol on the liver have been reported.
Mild -
What is the effect of Betnesol 0.5 Tablet (20) on the Heart?
Very few cases of side effects of Betnesol on the heart have been reported.
Mild
Severe Interaction of Betnesol 0.5 Tablet (20) with Other Drugs
Betnesol 0.5 Tablet (20) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
- Onco Bcg 40 Mg Injection
- Oncovac Vaccine
- Tubervac 40 Mg Injection
- BCG (Bacillus calmette-guerin) Injection
Moderate
- Wheezal Diabonol Drop
- Huminsulin R 100 IU/ml Cartridge
- Huminsulin R 100 IU/ml Injection
- Insuman Rapid 100 Solution for Injection
Betnesol 0.5 Tablet (20) Contraindications
If you are suffering from any of the following diseases, you should not take Betnesol 0.5 Tablet (20) unless your doctor advises you to do so -
- Allergy
- Liver Disease
- Infections
- Scleroderma
- Dehydration
- Tuberculosis (TB)
- Diabetes
- Diaper Rash
- Heart Disease
- Depression
- Crohn's Disease
Frequently asked Questions about Betnesol 0.5 Tablet (20)
-
Is this Betnesol 0.5 Tablet (20) habit forming or addictive?
No, you will not get addicted to Betnesol 0.5 Tablet (20).
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Betnesol 0.5 Tablet (20) since it does not cause drowsiness.
Safe -
Is it safe?
Betnesol 0.5 Tablet (20) is safe but it is important to consult a doctor before taking it.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Betnesol 0.5 Tablet (20) is not used to treat mental disorders.
No
Betnesol 0.5 Tablet (20) Interactions with Food and Alcohol
-
Interaction between Food and Betnesol 0.5 Tablet (20)
Due to a lack of research, nothing can be said about the consequences of taking Betnesol 0.5 Tablet (20) together with food.
Unknown -
Interaction between Alcohol and Betnesol 0.5 Tablet (20)
Due to lack of research, there is no information about the side effects of taking Betnesol 0.5 Tablet (20) with alcohol.
Unknown
See all substitutes for Betnesol
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)